Rongchang Biopharmaceutical (Yantai) Co., Ltd.
荣昌生物制药(烟台)股份有限公司Remegen Co., Ltd.Alias荣昌生物Alias
§01
Basic information
- Head office
- 58 Beijing Zhong Road, Yantai Development Zone, Yantai Free Trade Pilot Zone, Shandong, China
- Chief executive
- Wang Weidong
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2008-07-04
- End date
§02
Websites
§03
Business
Innovative biopharmaceutical company (antibody-drug conjugates ADC, antibody fusion proteins, monoclonal and bispecific therapeutic antibodies)Taitexip (the world's first dual-target therapeutic for systemic lupus erythematosus, brand name Taie, targets BLyS/APRIL)Vidisito monoclonal antibody (China's first domestically developed ADC innovative drug, brand name Aidi Xi, target HER2)Clinical solutions for autoimmune diseases, oncology, and ophthalmic diseases (product pipeline RC28, RC88, RC148, RC278, RC288)
§04
Related companies
—
§05
Network
Drag to move · click to open
§06
History
§07
News
There is no news.
§09